FORT LAUDERDALE, Fla., Nov. 4, 2010 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its RIO® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic procedures known as knee MAKOplasty®, today announced the pricing of the public offering of 5,500,000 shares of its common stock at a price to the public of $9.65 per share. Piper Jaffray & Co. acted as the sole underwriter for the offering.
